These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17299172)

  • 21. Antiemetic efficacy of the neurokinin-1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high-dose cisplatin: analysis of combined data from two Phase III randomized clinical trials.
    Gralla RJ; de Wit R; Herrstedt J; Carides AD; Ianus J; Guoguang-Ma J; Evans JK; Horgan KJ
    Cancer; 2005 Aug; 104(4):864-8. PubMed ID: 15973669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aprepitant for antiemesis after laparoscopic gynaecological surgery: A randomised controlled trial.
    Ham SY; Shim YH; Kim EH; Son MJ; Park WS; Lee JS
    Eur J Anaesthesiol; 2016 Feb; 33(2):90-5. PubMed ID: 26694939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addition of the Neurokinin-1-Receptor Antagonist (RA) Aprepitant to a 5-Hydroxytryptamine-RA and Dexamethasone in the Prophylaxis of Nausea and Vomiting Due to Radiation Therapy With Concomitant Cisplatin.
    Jahn F; Riesner A; Jahn P; Sieker F; Vordermark D; Jordan K
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1101-1107. PubMed ID: 26059352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of ramosetron versus ondansetron for postoperative nausea and vomiting after general anesthesia: a meta-analysis of randomized clinical trials.
    Gao C; Li B; Xu L; Lv F; Cao G; Wang H; Wang F; Wu G
    Drug Des Devel Ther; 2015; 9():2343-50. PubMed ID: 25960637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy.
    Warr DG; Hesketh PJ; Gralla RJ; Muss HB; Herrstedt J; Eisenberg PD; Raftopoulos H; Grunberg SM; Gabriel M; Rodgers A; Bohidar N; Klinger G; Hustad CM; Horgan KJ; Skobieranda F
    J Clin Oncol; 2005 Apr; 23(12):2822-30. PubMed ID: 15837996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matching groups for studying postoperative nausea and vomiting: should we care?
    Mraovic B; Simurina T
    Surg Endosc; 2010 Jul; 24(7):1796-7; author reply 1798-9. PubMed ID: 20044763
    [No Abstract]   [Full Text] [Related]  

  • 27. Midazolam vs ondansetron for preventing postoperative nausea and vomiting.
    Timms G
    Anaesthesia; 2007 Jun; 62(6):636-7; author reply 637. PubMed ID: 17506756
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevention of chemotherapy induced nausea and vomiting: a focus on aprepitant.
    Sankhala KK; Pandya DM; Sarantopoulos J; Soefje SA; Giles FJ; Chawla SP
    Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1607-14. PubMed ID: 19929449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A meta-analysis of aprepitant for prevention of chemotherapy-induced nausea and vomiting].
    Fang ZW; Zhai SD
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Dec; 42(6):756-63. PubMed ID: 21170111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aprepitant for postoperative nausea and vomiting.
    Gray H
    Anaesth Intensive Care; 2009 Jan; 37(1):135-6. PubMed ID: 19157363
    [No Abstract]   [Full Text] [Related]  

  • 31. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
    Poli-Bigelli S; Rodrigues-Pereira J; Carides AD; Julie Ma G; Eldridge K; Hipple A; Evans JK; Horgan KJ; Lawson F;
    Cancer; 2003 Jun; 97(12):3090-8. PubMed ID: 12784346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of nausea and vomiting associated with stem cell transplant: results of a prospective, randomized trial of aprepitant used with highly emetogenic preparative regimens.
    Stiff PJ; Fox-Geiman MP; Kiley K; Rychlik K; Parthasarathy M; Fletcher-Gonzalez D; Porter N; Go A; Smith SE; Rodriguez TE
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):49-55.e1. PubMed ID: 22863840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aprepitant when added to a standard antiemetic regimen consisting of ondansetron and dexamethasone does not affect vinorelbine pharmacokinetics in cancer patients.
    Loos WJ; de Wit R; Freedman SJ; Van Dyck K; Gambale JJ; Li S; Murphy GM; van Noort C; de Bruijn P; Verweij J
    Cancer Chemother Pharmacol; 2007 Feb; 59(3):407-12. PubMed ID: 17051369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials.
    Warr DG; Grunberg SM; Gralla RJ; Hesketh PJ; Roila F; Wit Rd; Carides AD; Taylor A; Evans JK; Horgan KJ
    Eur J Cancer; 2005 Jun; 41(9):1278-85. PubMed ID: 15939263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: a preliminary report.
    Habib AS; Gan TJ
    J Clin Anesth; 2005 Feb; 17(1):62-5. PubMed ID: 15721732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beyond current aprepitant evidence: room for improvement on dose selection and chemotherapy-induced nausea and vomiting risk factors.
    Okumura LM
    Support Care Cancer; 2016 Mar; 24(3):1009-10. PubMed ID: 26660150
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiemetic efficacy of combined aprepitant and dexamethasone in patients at high-risk of postoperative nausea and vomiting from epidural fentanyl analgesia.
    Kawano H; Matsumoto T; Hamaguchi E; Manabe S; Nakagawa M; Yamada A; Fujimoto M; Tada F
    Minerva Anestesiol; 2015 Apr; 81(4):362-8. PubMed ID: 25220550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethics, marketing, and the medical literature.
    Mychaskiw G; Badr AE; Calimaran AM
    Anesth Analg; 2006 Aug; 103(2):488; discussion 488; author reply 488-9. PubMed ID: 16861440
    [No Abstract]   [Full Text] [Related]  

  • 39. [When prophylaxis fails: Is treatment of postoperative nausea and vomiting with same-class antiemetics useful?].
    Zaballos M; Agustí S; García de Lucas E
    Rev Esp Anestesiol Reanim; 2005; 52(6):377-8. PubMed ID: 16038184
    [No Abstract]   [Full Text] [Related]  

  • 40. Dexamethasone, ondansetron, and their combination and postoperative nausea and vomiting in children undergoing strabismus surgery: a meta-analysis of randomized controlled trials.
    Shen YD; Chen CY; Wu CH; Cherng YG; Tam KW
    Paediatr Anaesth; 2014 May; 24(5):490-8. PubMed ID: 24612183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.